In health promotion, we have to bridge the knowledge gap and seek to find a common identity and solidarity between those sending and those receiving health messages. It goes beyond mere communication.
Read More
In times of crisis, messages that are not well understood can have grave consequences. So too can a lack of information. Messages need to be clear and constant, even obvious or – for some – absurd. Clarity is the key.
Read More
China’s extreme measures in the battle against Covid-19 led to a 90% decline in new infections within the country.
Read More
This article presents scenarios put forward by epidemiologists about what possible outcomes there are for the progression of the virus.
Read More
There are two principal reasons why an outbreak of an infectious virus is worrying. Firstly, viruses spread exponentially. Secondly, uncertainty in a virus outbreak is common, especially in the early weeks.
Read More
From a public health perspective, finding a vaccine is more valuable than developing treatments, as immunisation is a better way to prevent the spread of COVID-19 and to protect the populations of entire countries.
Read More
Responding to virus outbreaks is speed-crucial, not only in terms of containment decisions, but also how health authorities communicate health messages to the public.
Read More
More and more Language Services Providers (LSPs) are entering the regulatory area who, in turn, outsource this work to their in-country network. The people who actually do the label review are removed from the pharmaceutical company or CRO by up to four degrees and the end-client has no visibility at all of who is doing this work.
Read More
The complexity of the regulatory approval process for labels increases with each clinical phase, as patient numbers increase, from 10-20 patients in Phase 1 to 100-200 people in Phase II, to as many as 10 000 patients in a Phase III trial. As many Phase III trials are conducted across an increasing number of countries, the complexity of dealing with multiple regulatory agencies is magnified.
Read More
Over two-thirds of clinical studies are carried out outside of the USA. It is not unusual for Phase III trials, in particular, to be carried out in over 30 countries across five continents. More study sites outside of North America and the UK and EU region are being introduced each year, including in countries like Georgia and Guatemala.
Read More
Within the discipline of nuclear semiotics, there is an assumption that our current languages will have either gone extinct, diverged to the point of unintelligibility or there has been some kind of discontinuity or rupture between our civilizations now and those far in the future.
Read More